본문 바로가기
KERD
논문KCI 등재

구강 편평상피암종에서 CDH-13 유전자의 promoter methylation에 대한 연구

Promoter Methylation of the CDH-13 Gene in the Oral Squamous Cell Carcinoma

김경욱|한세진|이문주
대한구강악안면외과학회 (Korean Association Of Oral And Maxillofacial Surgeons)|2008.10|대한구강악안면외과학회지 (Journal of the Korean Association of Oral and Maxillofacial Surgeons)|제34권 제5호|pp. 525-531

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류치의학

초록

Abstract

CDH-13(T-cadherin), which is one of a kind among the 20 cadherins, can be found mainly in wall of aorta, neuron, spleen, blood vessel etc. It is also called H-cadherin. This structural difference can explain that CDH-13 is thought to play a key role in maintaining mutual relation between extra and intra-cellular environment rather than in cell adhesion. The main function of CDH-13 is to participate in blood vessel function. Additionally, it is known to regulate cell growth and cell contact inhibition. When cells are proliferating, cell surface perceives other cells so that substance such as CDH-13 can inhibit their growth or proliferation resulting in homeostasis without endless proliferation or invasion of connective tissue boundaries. However, tumor cell itself appears to be different from normal cells’ growth, invasion or transmission. Therefore, it can be diagnosed that these characteristics are closely related to expression of CDH-13 in tumor cells. This study is to investigate expression of CDH-13 in SCC and its correlation with promoter methylation. 20 of tissue species for the study are excised and gathered from 20 patients who are diagnosed as SCC in department of OMS, dental hospital, dankook university. To find development of CDH-13 in each tissue samples, immunohistochemical staining, RT-PCR gene analysis and methylation specific PCR are processed. The results are as follows. 1.Immunohistochemical staining: In normal oral squamous epithelial tissue, strong expression of CDH-13 was found in cell plasma membrane of basal cell layer. On the other hand, in case of low-differentiated oral SCC, development of CDH-13 was hardly seen. 2.The development of CDH-13 gene: In 9 of samples, expression of CDH-13 gene could be seen and 2 of them showed low expression compared to the others. And rest of the 11 samples showed no expression of CDH-13 gene. 3.Methylation of CDH-13 gene: Among 9 samples which expressed CDH-13 gene, 7 of them showed unmethylation. In addition, among 11 samples without CDH-13 gene expression, 10 showed methylation. According to the results stated above, promoter methylation were found in 13 samples(65%) among 20 of oral SCC samples. In low-differentiated SCC, suppression of gene expression could be seen accompanying promoter methylation. These phenomenon of gene expression was proved by immunohistochemical investigation. Finally, for development of oral SCC, conclusions can be made that suppression of CDH-13 played a main role and suppression of gene expression was originated from promoter methylation. Considering this, it is expected that suppression of CDH-13 from promoter methylation to be utilized as a good diagnostic marker of oral SCC.

참고문헌 (46)

  1. Cooper, Hausman, "The Cell ; A molecular approach", pp.4~ (2007), Sinaur Associates Inc
  2. Takeichi M, "Cadherin cell adhesion receptors as a morphogenetic regulator", Science, 251, pp.1451~1455 (1991)
  3. 표성운, "구강 편평세포암에서 E-cadherin 유전자의 과메틸화", 대한구강악안면외과학회지, 34(2), pp.135~140 (2008), 대한구강악안면외과학회
  4. Behrens J, "The role of cell adhesion molecules in cancer invasion and metastasis", Breast Cancer Res Treat, 24, pp.175~184 (1994)
  5. Ziober BL, "Adhesive mechanisms regulating invasion and metastasis in oral cancer, Crit", Rev. Oral Biol. Med, 12, pp.499~510 (2001)
  6. Oka H, "Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis", Cancer Res, 53, pp.1696~1701 (1993)
  7. Umbas R, "Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer", Cancer Res, 54, pp.3929~3933 (1994)
  8. Umbas R, "Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer", Cancer Res, 52, pp.5104~5109 (1992)
  9. Jiao W, "Inverse correlation between Ecadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo", Br. J. Cancer, 86, pp.98~101 (2002)
  10. Graff JR, "Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle’s cell, and poorly differentiated human thyroid carcinoma", Cancer Res, 58, pp.2063~2066 (1998)
  11. Schipper JH, "E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation withtumor dedifferentiation and lymph node metastasis", Cancer Res, 51, pp.6328~6337 (1991)
  12. Rodrigo JP, "Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features", Eur. J. Cancer, 38, pp.1059~1064 (2002)
  13. Tkachuk VA, "Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherin", FEBS Lett, 421, pp.208~212 (1998)
  14. Philippova MP, "T-cadherin and signal- transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells", FEBS Lett, 429, pp.207~210 (1998)
  15. Zhou S, "Expression of T-cadherin in basal keratinocytes of skin", J Invest Dermatol, 118, pp.1080~1084 (2002)
  16. Ranscht B, "T-cadherin, a novel cadherin adhesion molecule in the nervous system, lacks the conserved cytoplasmic region", Neuron, 7, pp.391~402 (1991)
  17. Takeuchi T, "Expression T-cadherin in human brain and its characteristics as a negative growth rgulator of EGF in neuroblastoma cells", J Neurochem, 74, pp.1489~1497 (2000)
  18. Takeuchi T, "Recent progress in T-cadherin (CDH13, H-cadherin) research", Histol Histopathol, 16, pp.1287~1293 (2001)
  19. Lee SW, "a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer", Nat Med, 2, pp.776~782 (1996)
  20. Lee SW, "H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo", Carcinogenesis, 19, pp.1157~1159 (1998)
  21. Sato M, "The Hcadherin(CDH13)gene is inactivated in human lung cancer", Hum Genet, 103, pp.96~101 (1998)
  22. Toyooka KO, "Loss of expression andaberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas", Cancer Res, 61, pp.4556~4560 (2001)
  23. Zhong Y, "Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity", Clin Cancer Res, 7, pp.1683~1687 (2001)
  24. Hatta K, "A monoclonal antibody disrupting calcium-dependent cell-cell adhesion of brain tissues: possible role of its target antigen in animal pattern formation", Proc Natl Acad Sci USA, 82, pp.2789~2793 (1985)
  25. Boller K, "Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells", J Cell Biol, 100, pp.327~332 (1985)
  26. Ozawa M, "Molecular organization of the uvomorulincatenin complex", J Cell Biol, 116, pp.989~996 (1992)
  27. Rubinfeld B, "Association of the APC gene product with beta-catenin", Science, 262, pp.1731~1734 (1993)
  28. Breen E, "Role of E-cadherin", α-catenin complex in modulating cell-cell and cell-matrix adhesive properties of invasive colon carcinoma cells, 1995, pp.2, 378~385
  29. Caca K, "β-catenin and γ-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor", lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer, 1999, pp.10, 369~376
  30. Mareel M, "E-cadherin", catenin, J Cell Physiol, pp.1997, 173[DOI]
  31. Takayama T, "β-Catenin expression in human cancers", Am J Pathol, 148, pp.39~46 (1996)
  32. Shimoyama Y, "Cadherin dysfunction in a human cancer cell line:possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness", Cancer Res, 52, pp.5770~5774 (1992)
  33. Oyama T, "A truncated β-Catenin disrupts the interaction between E-caherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines", Cancer Res, 54, pp.6282~6287 (1994)
  34. Jawhari A, "Abnormal immunoreactivity of the Ecadherin-catenin complex in gastric carcinoma: relationship with patient survival", Gastroenterology, 112, pp.46~54 (1997)
  35. Chang HW, "Loss of Ecadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance", Cancer, 94, pp.386~392 (2002)
  36. Melki JR, "Hypermethylation of E-cadherin in leukemia", Blood, 95, pp.3208~3213 (2000)
  37. Nakayama S, "The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas", Int. J. Cancer, 93, pp.667~673 (2001)
  38. Saito Y, "Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 50 CpG island", Int. J. Oncol, 12, pp.293~298 (1998)
  39. Ivanov D, "Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem", Cell Biol, 115, pp.231~242 (2001)
  40. Resink TJ, "LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions", FEBS Lett, 463, pp.29~34 (2000)
  41. Takeuchi T, "Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin", Mol. Carcinog, 35, pp.173~179 (2003)
  42. Toyooka S, "Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas", Cancer Res, 62, pp.3382~3386 (2002)
  43. Esteller M, "A gene hypermethylation profile of human cancer", Cancer Res, 61, pp.3225~3229 (2001)
  44. Tamotsu T, "Loss of T-cadherin (CDH13, Hcadherin) expression in cutaneous squamous cell carcinoma", Laboratory Investigation, 82, pp.1023~1029 (2002)
  45. Maruyama R, "Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features", Cancer Res, 61, pp.8659~8663 (2001)
  46. Kim JS, "Aberrant Methylation of H-Cadherin (CDH13) Promoter Is Associated with Tumor Progression in Primary Nonsmall Cell Lung Carcinoma", CANCER, 104, pp.1825~1832 (2005)

관련 논문AI추천

구강 편평세포암에서 E-cadherin 유전자의 과메틸화이원, 김영실, 김창현, 박민규, 박지영, 표성운대한구강악안면외과학회 · 대한구강악안면외과학회지2008 · 제34권 제2호구강편평상피암종에서 DCC 유전자의 역할고성규, 김경욱, 한세진대한구강악안면외과학회 · 대한구강악안면외과학회지2008 · 제34권 제5호구강 편평세포암종에서 E-cadherin의 발현과 임상병리학적 지표와의 관계김영실, 김창현, 신재명, 표성운대한구강악안면외과학회 · 대한구강악안면외과학회지2005 · 제31권 제1호Methylation Status and Expression of E-cadherin in Oral Squamous Cell Carcinomas Compared to Benign Oral Epithelial Lesions민명기, 손현진, 이동근, 이석근, 조남표, 조의식, 추정엽대한구강생물학회 · International Journal of Oral Biology2006 · 제31권 제2호구강설 편평세포암종에서 E-Cadherin과 Matrix Metalloproteinase-2의 발현김민식, 선동일, 이근석, 이수진, 조승호대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2003 · 제46권 제8호두경부 편평세포암종에서 메틸화 양상과 이형 접합성 소실김민식, 선동일, 유문간, 조승호, 홍명화, 홍승진대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2007 · 제50권 제2호

이 간행물의 다른 논문 (10건)

DNA 염기손상 치유유전자의 변이와 두경부암 발생 위험성최병준, 윤병욱, 오정환pp. 509-517구강편평상피암종에서 DCC 유전자의 역할김경욱, 한세진, 고성규pp. 518-524고농도 포도당 환경에서 EMD(Enamel Matrix Derivatives)가 인간 치주인대 세포와 뼈모세포양 세포(MC3T3-E1)에 미치는 영향이백수, 김선욱, 권용대, 주성숙pp. 532-536양측성 하악지 시상분할술을 이용한 악교정 수술시술 후 교합력과 근전도 변화최용관, 김경욱, 황대용, 이성규pp. 537-542가토에서 하악골 신장술이 악관절에 미치는 영향김경욱, 김철환, 임승규pp. 543-549
원문 보기